Hyphens Pharma International Ltd. (SG:1J5) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Hyphens Pharma International Ltd., a prominent Singapore-based specialty pharmaceutical firm, has secured an exclusive deal with MC2 Therapeutics to bring Wynzora Cream, a treatment for plaque psoriasis, to the ASEAN market. Wynzora Cream, already approved in several major markets including the US and various European countries, represents a significant expansion of Hyphens Pharma’s dermatological portfolio in Southeast Asia.
For further insights into SG:1J5 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue